SPOTLIGHT -
Skirmishes, Uncertainties, and Great Promise: Robert Green on Precision Medicine
"We are pitting the enthusiasm of the futurists...against the public health perspective that says ‘be careful what you screen for,’” the prominent genomicist says.
Mayo Clinic Attorney Tiptoes Through the Legal Landmines of Genomics
The FDA, GINA, and variants of unknown significance all muddy the waters of genomic research and data storage.
Nephi Walton Stresses Realism Regarding Precision Medicine
Certainly, Walton believes greatly in the potential of genomics to change medicine at its core, but the obstacles preceding that shift are numerous and substantial, he argued.